Showing 1341-1350 of 5231 results for "".
DermWireTV: Updates from ASDS: EBDs, Injectables, Scars, DEI
https://practicaldermatology.com/topics/practice-management/dermwiretv-updates-from-asds-ebds-injectables-scars-dei/20029/The annual meeting of the American Society for Dermatology Surgery (ASDS) brings together top dermatologists to share their expertise. This year’s virtual meeting offered a look at a range of new and emerging treatments and some updates on existing options, including insights from Jeanine B. Downie,Hair Care Trends You Need to Know
https://practicaldermatology.com/conferences/aad-summer-2021/hair-care-trends-you-need-to-know/19976/People are sharing more than their latest dance moves on TikTok. Many—with no background in science—are dispensing hair care advice, some of which could even be dangerous. Learn which trends you should know about in order to educate your patients about what really works versus what could do more harMuscle Makers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/muscle-makers/23541/The newest body sculpting technologies show promise for building muscle and strength.Diversity and Equity in Dermatology
https://practicaldermatology.com/topics/practice-management/diversity-and-equity-in-dermatology/23456/DermWireTV: Pulse's CellFX, Soliton's RAP Technology, Belotero Balance (+), Restylane Defyne, Eczema Costs
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-pulses-cellfx-solitons-rap-technology-belotero-balance-restylane-defyne-eczema-costs/19899/The FDA has cleared Pulse Biosciences’ CellFX system, and a commercial rollout will begin soon. There’s another new option for treatment for legs with FDA clearance of Soliton’s Rapid Acoustic Pulse technology for cellulite. For eight percent of Americans with atopic dermatitis, annual out of pocketWishful Thinking: Looking to the Year Ahead
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/wishful-thinking-looking-to-the-year-ahead/23435/Cosmetic Surgery Forum faculty share resolutions for 2021.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-17/23343/Rosacea Update: A Closer Look at Zilxi
https://practicaldermatology.com/columns/clinical-focus-1/rosacea-update-a-closer-look-at-zilxi/23339/Inside the approval of Zilxi for moderate-to-severe facial papulopustular rosacea.Vitiligo: Oral and Topical JAKs Show Promise
https://practicaldermatology.com/topics/pigmentary-disorders/vitiligo-oral-and-topical-jaks-show-promise/23316/Early studies offer some hope for emerging therapies for repigmentation.6 Tools That Can Benefit Every Dermatology Provider
https://practicaldermatology.com/topics/practice-management/6-tools-that-can-benefit-every-dermatology-provider/23283/Whether you’ve never heard of it or simply forgot about it, each of these tools can improve patient care in the clinic.